Filing Details

Accession Number:
0000711377-10-000022
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-04 21:30:32
Reporting Period:
2010-10-01
Filing Date:
2010-10-04
Accepted Time:
2010-10-04 21:30:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188987 A Terri Morrical Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-01 3,882 $9.09 14,156 No 4 M Direct
Common Stock Disposition 2010-10-01 3,882 $34.11 10,274 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option (Right to buy) Disposition 2010-10-01 3,882 $9.02 3,882 $9.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
41,438 2011-11-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,564 Indirect Held in Neogen 401-K Plan
Footnotes
  1. The options were granted 11/3/06 as NQ options and became vested 20% yearly thereafter.